With Research Expenditures of More Than $892.7 Million, Texas A&M's Division of Research delivers strategic support to advance the University's research mission through:Read More
Science Market Update
The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Childrens Hospital in Houston is a leading research institution continuously making breakthroughs in the field of neurological research on topics such as autism, Alzheimer's and epilepsy. Now, thanks to Charif Souki, co-founder of Tellurian, the NRI will have an additional $10 million to further their life science research. (Image courtesy of Zereshk via Wikimedia Commons)Read More
The state of Texas is striving to increase cancer research capabilities and opportunities with the Cancer Prevention and Research Institute of Texas (CPRIT). One method that CPRIT uses to increase cancer research opportunities throughout the state is through the institutes core facility support awards, which provide more funding and opportunities for researchers from different Texas institutions. Recently, researchers from Texas A&M University received a $5.7 million grant from CPRIT to expand cancer research at the university through this additional core facility funding. (Image courtesy of Aggie0083 via Wikimedia Commons)Read More
Does your Lab Equipment and Product Territory Include Texas?
The Texas Medical Center has recently fostered a $25 million initiative designed to support technologies and early-stage companies and to further the TMC’s mission to advance health, education and research.
"The Texas Medical Center unveiled plans for the TMC Venture Fund to an audience of more than 600 investors, hospital stakeholders, advisors and members of Houston’s innovation ecosystem" see press release. For those wondering just how big this is compared to the overall Texas Medical Center research marketplace, current estimates for the size of this market range from $1.8 Billion to $2.2 Billion.
Tags: Biotech Event, Texas Medical Center, Texas, Healthcare, tmc, Biotechnology, TX, lab equipment, Southwest Region, Biotech vendor, Lab Sales, Lab Supply, best lab supply tradeshows, best science tradeshows, BioResearch Product Faire™
Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods.
Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)Read More
Traumatic brain injury, or TBI, is the leading cause of disability among U.S. military personnel and veterans. What’s more, 50% of people with TBI develop spontaneous seizures. If the seizures become recurrent then the condition qualifies as Post-Traumatic Epilepsy, PTE. Now thanks to a 3 year, $750,000 research grant from the Department of Defense and the Army, researchers at Texas A&M will conduct a study on TBI to uncover the molecular and epigenetic mechanism of PTE.Read More
The Texas Medical Center is growing yet again, amid the imminent renovation and expansion of the Memorial Hermann-Texas Medical Center Campus. (image source: memorialhermann.org)Read More
Tags: Biomedical expansion, Medical Research, new medical facility, Texas Medical Center, Texas, Research Funding, TX, Southwest Region, new Building, research facilities, new medical buildings, 2016, BioResearch Product Faire™, Memorial Hermann
Carbon emissions may be at an all time high, but thanks to research currently being conducted at Texas A&M University (TAMU), clearer skies may be in our future.Read More
Sézary syndrome is a rare form of T-cell lymphoma that causes different types of lesions to appear on the skin once. Very little is known about the cause of this cancer, and there are no current cures available. Researchers from Baylor College of Medicine and the MD Anderson Cancer Center in Houston, Texas have identified certain genes that, when mutated, appear to play a role in Sézary syndromeRead More